Skip to main content

This job has expired

You will need to login before you can apply for a job.

Associate Director/Director, Regulatory Strategy

Employer
Omega Therapeutics
Location
Cambridge, MA
Start date
Sep 14, 2021

View more

Discipline
Marketing, Regulatory, Regulatory Affairs
Required Education
Bachelors Degree
Position Type
Full time
Hotbed
Genetown, NextGen Bio

Job Details

Omega Therapeutics is a development-stage biotechnology company pioneering a new class of programmable, mRNA-encoded therapeutics to transform human medicine. The OMEGA Epigenomic Programming™ platform harnesses the power of epigenetics, the mechanism that controls gene expression and every aspect of an organism's life from cell genesis, growth and differentiation to cell death. The OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by returning aberrant gene expression to a normal range without altering native nucleic acid sequences. Omega’s engineered, modular, and programmable mRNA-encoded epigenetic medicines, Omega Epigenomic Controllers™, target specific intervention points amongst the thousands of validated novel DNA-sequence-based epigenomic targets we have mapped to tune single or multiple genes to treat and cure disease through Precision Genomic Control™. Omega is currently advancing a broad pipeline of development candidates spanning a range of disease areas, including oncology, regenerative medicine, multigenic diseases including immunology, and select monogenic diseases.

About the Role:

Omega Therapeutics, Inc. is seeking an Associate Director/Director, Regulatory Strategy (commensurate with experience) to join our growing Regulatory Science team.  As a Regulatory Science team member, they will work with the FDA and EMA, as well as national regulatory authorities globally to find innovative ways to collaborate. 

We seek an experienced regulatory strategist who will provide robust and creative regulatory strategies to support the expedited and efficient development of Omega’s innovative DNA-sequence-targeting, mRNA-encoded products.  You will be responsible for the preparation, submission, and approval of INDs, CTAs, orphan drug designations, and managing corresponding interactions with regulatory authorities. 

Key Responsibilities:

  • Understanding and interpreting complex scientific issues as they relate to regulatory requirements and strategy for assigned projects, and provide knowledge and expertise to guide the team on appropriate regulatory strategies
  • Manage preparation and submission of high-quality dossiers including development of timelines
  • Collaborate with regulatory-CMC, regulatory operations, and other functions to ensure seamless integration of various components into submissions as well as high quality submissions
  • Lead transparent and proactive interactions with regulatory agencies globally
  • Drive adherence to regulatory guidelines for development of gene therapy products
  • Maintains knowledge of relevant evolving regulation and guidance; review draft regulatory guidelines and monitor trends

 Required Skills:

  • Knowledgeable in ICH, FDA and EMA guidelines
  • Experience in oncology or rare disease is preferred
  • Understanding of advanced therapy products development
  • Ability to work effectively in a collaborative, team environment
  • Independently motivated, detail oriented, and good problem-solving ability
  • Excellent organizational skills, with an ability to embrace change and multi-task in an extremely fast-paced environment
  • Excellent communications skills and ability to influence across multiple functions

Required Qualifications:

  • BA/BS degree in life sciences, MS/PhD preferred
  • Relevant experience in the Biotech/Pharmaceutical Industry, including 5-7 years within Regulatory Affairs
  • Experience leading Agency meetings and IND and/or CTA activities

Company

Omega Therapeutics is a publicly held, development-stage biotechnology company pioneering a new class of DNA-sequence-targeting, mRNA-encoded therapeutics to transform human medicine. The OMEGA Epigenomic Programming™ platform harnesses the power of epigenetics, the mechanism that systematically controls every aspect of an organism’s life from cell genesis, to growth and differentiation. The OMEGA platform has identified thousands of novel DNA-sequence-based epigenomic targets within Insulated Genomic Domains (IGDs), referred to as EpiZips™. IGDs represent the three-dimensional, distinct, and evolutionarily conserved architecture of the genome, and are the fundamental structural and functional units of gene control and cell differentiation. They act as the “control room” of biology. The OMEGA platform examines alterations in IGDs leading to aberrant gene expression, a cause of most disease. It then leverages its database of EpiZips to identify appropriate intervention points within the IGDs and rationally designs biologically engineered, modular, and programmable mRNA-encoded epigenetic medicines, called Omega Epigenomic Controllers™, to target EpiZips for Precision Genomic Control™. With its computation- and data-first approach, Omega Therapeutics is currently advancing a broad pipeline of programs that span regenerative medicine, multigenic diseases including immunology, oncology, and select monogenic diseases.

Twitter

Company info
Website
Phone
(617) 949-4359
Location
140 First Street
Cambridge
MA
02141
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert